Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study

Gullvi Flensner, Anne-Marie Landtblom, Olle Söderhamn, Anna-Christina Ek, Gullvi Flensner, Anne-Marie Landtblom, Olle Söderhamn, Anna-Christina Ek

Abstract

Background: Among individuals diagnosed with the chronic neurologic disease, multiple sclerosis (MS), a majority suffers from fatigue, which strongly influences their every-day-life. The aim of this study was to investigate work capacity and health-related quality of life (HRQoL) in a group of MS patients and also to investigate if work capacity and HRQoL could be predicted by background factors, fatigue, heat sensitivity, cognitive dysfunction, emotional distress or degree of disability.

Methods: A descriptive, cross-sectional, designed survey was undertaken A questionnaire was sent to 323 individuals diagnosed with MS, aged between 20 and 65 years, with physical disability on the expanded disability status score (EDSS) in the interval 0 ≥ EDSS ≤ 6.5, living in Östergötland county in eastern Sweden. Questions on background factors, occupation and work, together with the health-related quality of life short form instrument (SF-36), the fatigue severity scale (FSS), the perceived deficit questionnaire (PDQ) and the hospital anxiety depression scale (HAD) were posed. Associations between variables were analyzed using Pearson's and Spearman's correlations. Differences between groups were tested using the Chi-square test, the Mann Whitney U-test, and the Student's t-test. Predictive factors were analyzed using multiple linear and multiple logistic regression analysis.

Results: Of those who completed the questionnaire (n = 257, 79.6%), 59.8% were working. Work capacity was found significantly more among men (p < 0.005), those with a higher level of education (p < 0.001), those reporting less fatigue (p < 0.001), and those having no heat sensitivity (p = 0.004). For work capacity, significant predictors were low physical disability (EDSS), low fatigue, higher level of education, male sex and lower age. Those with work capacity showed significantly higher HRQoL than those who had no work capacity (p < 0.001). Levels of fatigue, cognition and emotional distress were found to be major contributing factors for HRQoL.

Conclusions: Work capacity and HRQoL among individuals diagnosed with MS are highly influenced by fatigue which can be considered as a key symptom. Work capacity was influenced by heat-sensitivity, cognitive difficulties and emotional distress and significant predictive factors besides fatigue, were physical disability (EDSS), age, sex, and level of education. Remaining at work also gives a better HRQoL.

References

    1. Hamilton WT, Hall GH, Round AP. Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: a case–control study. Brit J Gen Pract. 2001;51:553–558.
    1. Kant IJ, Bültmann U, Schröer K, Beurskens A, van Amelsvoort L, Swaen G. An epidemiological approach to study fatigue in the working population: the Maastricht cohort study. Occup Env Med. 2003;60(Suppl I):i32–i39.
    1. Flensner G, Ek A-C, Landtblom A-M, Söderhamn O. Fatigue in relation to perceived health: people with MS compared to people in the general population. Scand J Caring Sci. 2008;22(3):391–400. doi: 10.1111/j.1471-6712.2007.00542.x.
    1. Sullivan PS, Dworkin MS. and the Adult and Adolescent Spectrum of HIV Disease Investigators. Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symptom Manage. 2003;25:329–333. doi: 10.1016/S0885-3924(02)00676-0.
    1. Piper BF. In: Pathophysiological phenomena in nursing. Human responses to illness. Third. Carrieri-Kohlman V, Lindsey A, West C, editor. Philadelphia: Saunders; 2003. Fatigue. Chapter 11.
    1. Flensner G, Ek A-C, Söderhamn O. Lived experience of MS-related fatigue – a phenomenological interview study. Int J Nurs Stud. 2003;40:707–717. doi: 10.1016/S0020-7489(03)00010-5.
    1. Lerdal A, Wahl AK, Rustøen T, Hanestad BR, Moum T. Fatigue in the general population: a translation and psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Publ Health. 2004;32:1–8. doi: 10.1080/14034940410024194.
    1. Freal J, Kraft G, Coryell J. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil. 1984;65:135–138.
    1. Krupp LB, Christodoulou C. Fatigue in multiple sclerosis. Curr Neurol Neurosci. 2001;I:294–298.
    1. Yorkston KM, Johnson K, Klasner ER, Amtmann D, Kuehn CM, Dudgeon B. Getting the work done: a qualitative study of individuals with multiple sclerosis. Disabil Rehabil. 2003;25:369–379. doi: 10.1080/0963828031000090506.
    1. Amato MP, Ponziani G, Rossi F, Leidi CL, Stefaile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. J Neurol Sci. 2006;243:39–45. doi: 10.1016/j.jns.2005.11.025.
    1. Ghaem H, Borhani Haghighi A. The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis. Ann Indian Acad Neurol. 2008;11(4):236–241. doi: 10.4103/0972-2327.44559.
    1. Vukusic S, Confavreux C. In: Handbook of multiple sclerosis. Third. Cook SD, editor. New York: Marcel Dekker Inc; 2001. The natural history of MS; pp. 433–447.
    1. Boström I, Riise T, Landtblom AM. Mortality statistics for multiple sclerosis and amytrophic lateral sclerosis in Sweden. Neuroepidemiology. 2012;38(4):245–249. doi: 10.1159/000338031.
    1. European Multiple Sclerosis Platform (EMSP) A code of good practice on the rights and quality of life of people affected by multiple sclerosis 2008. .
    1. Ahlgren C, Odén A, Lycke J. High nationwide prevalence of multiple sclerosis in Sweden. Mult Scler. 2011;17(8):901–908. doi: 10.1177/1352458511403794.
    1. Boström I, Callander M, Kurtzke JF, Landtblom AM. High prevalence of multiple sclerosis in the Swedish county of värmland. Mult Scler. 2009;15:1253–1262. doi: 10.1177/1352458509345909.
    1. Boström I, Stawiarz L, Landtblom AM. Sex ratio of multiple sclerosis in the national Swedish MS register (SMSreg) Mult Scler. 2013;19(1):46–52. doi: 10.1177/1352458512446169.
    1. Forbes A, While A, Mathes L, Griffiths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil. 2006;20:67–78. doi: 10.1191/0269215506cr880oa.
    1. Patrick E, Christodoulou C, Krupp LB. on behalf of the New York State MS Consortium. Longitudinal correlates of fatigue in multiple sclerosis. Mult Scler. 2009;15:258–261.
    1. Krupp L, Elkins L. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology. 2000;55(7):934–939.
    1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991;41:685–691. doi: 10.1212/WNL.41.5.685.
    1. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991;41:692–696. doi: 10.1212/WNL.41.5.692.
    1. MacAllister WS, Belman AL, Milazzo M, Weisbrot DM, Christodoulou C, Scherl WF, Preston TE, Cianciulli C, Krupp LB. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology. 2005;64:1422–1425. doi: 10.1212/01.WNL.0000158474.24191.BC.
    1. Christodoulou C, Melville P, Scherl WF, Morgan T, MacAllister W, Canfora DM, Berry SA, Krupp LB. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis. JINS. 2005;11:614–619.
    1. Glad SB, Nyland H, Aarseth JH, Riise T, Myhr KM. How long can you keep working with benign multiple sclerosis? J Neurol Neurosurg Psychiatry. 2011;82(1):78–82. doi: 10.1136/jnnp.2010.210732.
    1. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignan H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sc. 2006;243(1–2):39–45.
    1. Syndulko K, Jafari M, Woldanski A, Baumhefner RW, Tourtellotte WW. Effects of temperature in multiple sclerosis: a review of the literature. J Neurol Rehabil. 1996;10:23–34.
    1. Flensner G, Lindencrona C. The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis. J Adv Nurs. 2002;37:541–550. doi: 10.1046/j.1365-2648.2002.02129.x.
    1. Lerdal A, Celius EG, Krupp L, Dahl AA. A prospective study of fatigue in multiple sclerosis. Eur J Neurol. 2007;14:1338–1343. doi: 10.1111/j.1468-1331.2007.01974.x.
    1. Flensner G, Ek A-C, Söderhamn O, Landtblom AM. Sensitivity to heat in MS patients: a factor strongly influencing symptomology – an exploratory survey. BMC Neurol. 2011;11:27. doi: 10.1186/1471-2377-11-27.
    1. Meier DS, Christodoulou C. MS and heat - the smoke and the fire. Neurology. 2012;78:938–939. doi: 10.1212/WNL.0b013e31824de2ac.
    1. Leavitt VM, Sumowski JF, Chiaravalloti N, DeLuca J. Warmer outdoor temperature is associated with worse cognitive status in multiple sclerosis. Neurology. 2012;78:964–968. doi: 10.1212/WNL.0b013e31824d5834.
    1. Berg J, Lindgren P, Fredrikson S, Kobelt G. Costs and quality of life of multiple sclerosis in Sweden. Eur J Health Econ. 2006;7(Suppl 2):S 75–S 85.
    1. Pfleger CC, Flachs EM, Koch-Henriksen N. Social consequences of multiple sclerosis 1): early pension and temporary unemployment-a historical prospective cohort study. Mult Scler. 2010;16(1):121–126. doi: 10.1177/1352458509352196.
    1. Sundström P, Nyström L, Svenningsson A, Forsgren L. Sick leave and professional assistance for multiple sclerosis individuals in Västerbotten County, northern Sweden. Mult Scler. 2003;9(5):515–520. doi: 10.1191/1352458503ms955oa.
    1. Olofsson S, Wickström A, Häger Glenngård A, Persson U, Svenningsson A. Effect of treatment with Natalizumab on ability to work in people with MS - Productivity gain based on a direct measurement of working capacity before and after 1 year of treatment. Bio Drugs. 2011;25(5):299–306.
    1. Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Andersen O. Early immunotherapy in MS reduces the risk of later disability. Lakartidningen. 2007;104(22):1684–1688.
    1. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in MS: results of an open label trial. Neurol. 1996;46:552–553. doi: 10.1212/WNL.46.2.552.
    1. Putzki N, Yaldizli O, Tettenborn B, Diener HC. Multiple sclerosis associated fatigue during natalizumab treatment. J Neurol Sc. 2009;285:109–113. doi: 10.1016/j.jns.2009.06.004.
    1. Landtblom AM, Flensner G, Callander M, Stawiarz L. The Swedish MS registry points out an important clinical problem: physical and psychological fatigue is a main symptom in multiple sclerosis. Lakartidningen. 2004;101(44):3456–3457.
    1. Kurtzke J. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) Neurol. 1983;33:1444–1452. doi: 10.1212/WNL.33.11.1444.
    1. Ware JE, Sherbourne CD. The MOS 36-item short form healthy survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483. doi: 10.1097/00005650-199206000-00002.
    1. Sullivan M, Karlsson J, Ware J Jr. The Swedish SF-36 health survey-1. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41:1349–1358. doi: 10.1016/0277-9536(95)00125-Q.
    1. Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51:1105–1113. doi: 10.1016/S0895-4356(98)00102-4.
    1. Taft C, Karlsson J, Sullivan M. Performance of the Swedish SF- 36 2.0. Qual Life Res. 2004;13:251–256.
    1. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988;45:435–437. doi: 10.1001/archneur.1988.00520280085020.
    1. Johansson S, Ytterberg C, Back B, Widén Holmquist L, von Koch L. The Swedish occupational fatigue inventory in people with multiple sclerosis. J Rehab Med. 2008;40:737–743.
    1. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334. doi: 10.1007/BF02310555.
    1. Sullivan JIL, Edgeley K, Dehoux E. A survey of multiple sclerosis. Part I: perceived cognitive problems and compensatory strategy used. Can J Rehabil. 1990;4:99–105.
    1. Streiner DL, Norman GR. Health measurement scales. Fourth. Oxford: Oxford University Press; 2008. (A practical guide to their development and use).
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. WMA, World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Seoul, Korea: 59th WMA General Assembly; 2008.
    1. Krokavcova M, Naqyova I, Van Dijk JP, Rosenberger J, Gavelova M, Middel B, Szilasiova J, Gdovinova Z, Groothoff JW. Self-rated health and employment status in patients with multiple sclerosis. Disabil Rehabil. 2010;32(21):1742–1748. doi: 10.3109/09638281003734334.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere